Complete Consumer Guide · Updated May 2026

Semaglutide & Tirzepatide: Everything You Need to Know

May 2026  |  BetterNewLives.com

Ozempic, Wegovy, Mounjaro, and Zepbound are among the most significant medications of the last decade — and among the most expensive, most confusing, and most unevenly accessible. This hub brings together every guide, tool, and resource we've built to help consumers navigate cost, coverage, quality, and access. All in one place.

🛠️ Interactive Tools
📄

Free Letter Templates — Prior Auth, Insurance Appeal, HR Request & More

5 copy-paste templates for the hardest GLP-1 coverage moments. Prior authorization support letter, insurance denial appeals (4 denial-reason variants), employer HR coverage request, hardship pricing email, and external review request. Free to copy and use.

💰 Cost, Access & Savings
🛡️ Insurance & Coverage Navigation
🔬 Quality, Safety & Program Comparison
Clinical
Compounded vs. Brand-Name GLP-1
503A vs. 503B compounding pharmacies, FDA shortage framework, red flags and quality signals. What to look for before choosing a compounded program.
Read guide →
Guide
Program Hidden Terms: Fine Print Guide
Cancellation windows, refund policies, auto-renewal terms, dose-matching when you switch, and record portability — the terms programs don't advertise prominently.
Read guide →
Prices
Semaglutide Programs: Side-by-Side
Found, Hims & Hers, Noom Med, Henry Meds, Ro Body — entry prices, standard prices, what's included, and who each program is best for.
Compare programs →
Prices
Tirzepatide Programs: Side-by-Side
Henry Meds, Hims & Hers, Ro Body, Found, Eden — entry prices, standard prices, what's included, and program notes for tirzepatide.
Compare programs →
Policy Analysis
Why GLP-1 Medications Are Inaccessible to Most Americans
Pharma pricing, insurance exclusions, FDA compounding policy, and the patients caught in the middle — an attorney's independent analysis of a structural public health failure.
Read analysis →
Decision Guide
Your GLP-1 Options in 2026: Every Tier Explained
Brand-name to research peptide — every access tier mapped honestly with costs, risks, and who each option is right for. No affiliate links, no vendor promotion.
See all options →
Legal Explainer
The Compounding Crackdown: What Happened in 2025–2026
The FDA shortage exception, why it ended for semaglutide, court challenges, the base-vs-salt dispute, and where compounded tirzepatide stands today.
Read explainer →
Guide
GLP-1 Compounding Pharmacies: How to Compare
Eden, Hims/Hers, Ro, Henry Meds, Hallandale, and others — how the supply chain works, what to ask any pharmacy, quality red flags, and the 2026 semaglutide regulatory situation.
Read guide →
Regulatory
What Is Compounding — and When Is It Legal?
503A vs. 503B pharmacies, the drug shortage exception, what changed in 2024–2026, the semaglutide base vs. salt dispute, and what patients need to understand about compounded GLP-1s.
Read guide →
Platform Review
Eden Health GLP-1 Review 2026
How Eden's compounded tirzepatide program works, current pricing ranges, which pharmacy partner to ask about, pre-signup checklist, and how Eden compares to Hims/Hers, Ro, and Henry Meds.
Read review →
Consumer Protection
How to Vet a GLP-1 Telehealth Platform
Red flags, billing fraud patterns, how to cancel safely, FCBA dispute rights, and a pre-enrollment checklist for any telehealth program — before you hand over your credit card.
Read guide →
Consumer Protection
Mochi Health and the State Pharmacy Investigation: What Patients Need to Know
State pharmacy board investigations into Mochi Health's compounding practices — what was alleged, what it means for current patients, and how to evaluate your own program's pharmacy relationships.
Read guide →
Policy Analysis
Canada Generic Semaglutide: What US Patients Should Know
Generic semaglutide is approved and available in Canada. Legal importation status, cost differences, quality considerations, and the practical reality of cross-border access for US patients.
Read guide →
Policy Analysis
RFK Jr. and Peptide Reclassification: What the Policy Change Would Mean for Patients
An analysis of the proposed peptide reclassification under RFK Jr.'s HHS leadership — what's being considered, what it would mean for access and pricing, and what patients and researchers need to watch.
Read guide →
Regulatory
Compounded Semaglutide: Base Form vs. Salt Form — What the Science Says
The FDA's position on semaglutide sodium and acetate salts vs. the base form, what the chemical differences mean for bioavailability and safety, and why this dispute matters for patients.
Read guide →
Safety Guide
Compounded GLP-1 Dosing and Concentration Safety
Compounded vials vary in concentration — the same volume can deliver very different doses depending on the formulation. How to verify your concentration, calculate doses correctly, and avoid dangerous errors.
Read guide →
Consumer Protection
GLP-1 Telehealth Provider Fraud and Consumer Protection
Unauthorized billing, misleading cancellation policies, unlicensed prescribing, and other fraud patterns in the GLP-1 telehealth market — your rights, reporting options, and how to dispute charges.
Read guide →
Policy Analysis
Generic GLP-1 Pricing and Prescription Wording
What generic semaglutide and tirzepatide pricing could look like, how prescription wording affects what pharmacies can dispense, and what patients and prescribers need to know as the patent landscape shifts.
Read guide →
🩺 Clinical Understanding
Clinical
How Long Do You Need to Take GLP-1 Medications?
For most patients, benefits require long-term treatment. What the trial evidence shows, what this means for your financial planning, and the most sustainable long-term options.
Read guide →
Clinical
What Happens When You Stop
The STEP-4 trial: most people regain 2/3 of lost weight within one year of stopping. What that means, maintenance dose options, and what to do if cost forces a stop.
Read guide →
Clinical
Managing Side Effects — Stay on Treatment
Nausea, fatigue, and GI changes are the #1 reason people quit. Evidence-based strategies to manage each side effect, slow escalation timing, and red flags to watch for.
Read guide →
Clinical
Semaglutide vs. Tirzepatide: Which Is Right for You?
Head-to-head comparison of the two leading GLP-1 medications. STEP-1 vs. SURMOUNT-1 trial data, side effect differences, cost, coverage, and which to ask about for your situation.
Read guide →
Clinical
Breaking Through a GLP-1 Weight Loss Plateau
What causes plateaus (metabolic adaptation, dose ceiling, behavioral drift), how to tell if it's a true plateau, dose reassessment, dietary audit, and when switching medications makes sense.
Read guide →
Clinical
Switching Between GLP-1 Medications
How to transition from semaglutide to tirzepatide (or vice versa) — no washout needed, starting dose guidance, what to expect, insurance considerations, and the retatrutide pipeline.
Read guide →
Clinical
GLP-1 Emotional Blunting: What the Evidence Shows
Reports of reduced motivation, anhedonia, and emotional flatness on GLP-1s are real but understudied. An honest look at the dopamine hypothesis, who seems most affected, and what to watch for.
Read guide →
Clinical
GLP-1 Benefits Beyond Weight Loss
SELECT trial (20% CV risk reduction), FLOW trial (kidney protection), cancer data, Alzheimer's signals, addiction research, and testosterone — evidence graded by strength from established to emerging.
Read guide →
Metabolic Science
Peptides & Fat Metabolism: Visceral Fat, Subcutaneous Fat & BMR
How GLP-1s preferentially reduce visceral fat, adaptive thermogenesis and why your metabolism slows, and what the evidence shows for AOD-9604, MOTS-c, and GHRH peptides on fat metabolism.
Read guide →
Longevity Science
Peptides & Metabolic Age: What the Science Actually Shows
What biological age really means, how to measure it (epigenetic clocks, PhenoAge, VO2 max), and honest evidence assessments for Epithalon, GHK-Cu, MOTS-c, and GLP-1 effects on aging markers.
Read guide →
Clinical
Gallbladder Risk on GLP-1 Medications: What Patients Need to Know
GLP-1 medications increase gallstone and cholecystitis risk, especially with rapid weight loss. What the evidence shows, symptoms to watch for, and how to reduce your risk.
Read guide →
Clinical
Malnutrition Risk on GLP-1 Medications: When Appetite Suppression Goes Too Far
Severe appetite suppression can lead to inadequate protein, micronutrient deficiencies, and muscle loss. Warning signs, nutritional strategies, and when to reassess your dose.
Read guide →
Comparison
GLP-1 Medications vs. Bariatric Surgery: A Neutral Comparison
Weight loss outcomes, complication profiles, cost, reversibility, and long-term data — a neutral side-by-side comparison to help patients and providers think through both options.
Read guide →
Clinical
GLP-1 Medications and Thyroid Cancer: What the FDA Warning Actually Means
The FDA black box warning flags thyroid C-cell tumor risk seen in rodent studies. What the human evidence actually shows, who it matters for, and how to think about the risk.
Read guide →
Clinical
GLP-1 Medications and Illness: When Delayed Gastric Emptying Becomes a Risk
GLP-1s slow gastric emptying — which creates real risks during illness, surgery, and anesthesia. Sick-day management, surgical timing, and medication interaction guidance.
Read guide →
Clinical
GLP-1 Medications and Fertility: What to Know Before Trying to Conceive
GLP-1s are not recommended during pregnancy. What the current guidance says, when to stop before trying to conceive, and what the fertility data shows.
Read guide →
Clinical
Injection Site Technique, Rotation, and Scarring: A Practical Guide
Proper injection technique, rotation schedules to prevent lipohypertrophy, how to recognize early scarring, and what to do if absorption seems to be declining.
Read guide →
Clinical
Retaining Muscle on GLP-1 Medications: Protein, Creatine, and What the Evidence Shows
GLP-1-driven weight loss includes lean mass loss. Protein targets, creatine evidence, resistance training, and dose management strategies to preserve muscle.
Read guide →
Clinical
Why Bryan Johnson Stopped Tirzepatide: GLP-1s, Heart Rate, Sleep, and Longevity
Bryan Johnson's documented decision to stop tirzepatide — what his biometric data showed about heart rate, sleep, and longevity trade-offs, and what it means for people using GLP-1s for reasons beyond weight loss.
Read guide →
Clinical
Weight Loss Plateaus on GLP-1 Medications
Why plateaus happen on GLP-1 therapy, how to distinguish a true metabolic plateau from dose ceiling or behavioral drift, and evidence-based strategies for breaking through or reassessing treatment.
Read guide →
Clinical
Loose Skin During GLP-1 Weight Loss
What determines loose skin after weight loss on GLP-1 medications — rate of loss, age, genetics, muscle retention — and what the evidence shows for minimizing it during treatment.
Read guide →
Clinical
GLP-1 Medications for Adolescents
FDA approvals for adolescent use, what the trial evidence shows for patients under 18, prescribing criteria, parental and provider considerations, and how coverage differs for minors.
Read guide →
Clinical
What Happens When You Stop GLP-1 Medications
Weight regain timelines, metabolic rebound, how to taper vs. stop abruptly, maintenance strategies, and what the clinical evidence says about long-term discontinuation outcomes.
Read guide →
Clinical
Emotional and Mental Health Effects of GLP-1
Depression, anxiety, emotional blunting, reduced impulsivity, and mood changes reported on GLP-1 medications — what the evidence shows, who is most affected, and what to discuss with your provider.
Read guide →
Clinical
Long-Term GLP-1 Tolerance and Resistance
Does efficacy diminish over time? What the long-term trial data shows about tolerance, receptor downregulation, waning appetite suppression, and how to think about lifetime therapy management.
Read guide →
Clinical
Nutrition and Eating Guide While on GLP-1
How to meet protein and micronutrient needs when appetite is suppressed, foods that minimize GI side effects, meal timing, and evidence-based dietary strategies to maximize outcomes on GLP-1 therapy.
Read guide →
Clinical
Switching Between GLP-1 Medications
When and how to switch from one GLP-1 to another — transition protocols, starting dose considerations, what to expect clinically, insurance implications, and the emerging pipeline options.
Read guide →
📊 Live Price Comparisons
🧬 Research Peptide Guides
Research Guide
Semaglutide Research Peptide: Overview & Prices
How Semaglutide works as a GLP-1 agonist, what the STEP trials showed, dosing context, and how to compare prices across US research suppliers.
Read guide →
Research Guide
Tirzepatide Research Peptide: Overview & Prices
Tirzepatide's dual GLP-1/GIP mechanism, SURMOUNT trial data showing 22.5% average weight loss, and a side-by-side comparison with Semaglutide.
Read guide →
Research Guide
Retatrutide: The Triple GLP-1/GIP/Glucagon Agonist
What makes Retatrutide different, how the triple mechanism works, and what phase 2 trials showing 24%+ weight loss mean for researchers.
Read guide →
Prices
Retatrutide Price Comparison & Supplier Guide
How to find the best Retatrutide research peptide price, what sizes are available, what to look for in a supplier, and how costs compare to Semaglutide and Tirzepatide.
Compare prices →
Research
Peptide Testing: What CoAs Show (and What They Don't)
43% of independently tested peptides failed in 2024. What HPLC tests actually measure, why Janoshik's public database is structurally cherry-picked, and how to read a certificate of analysis.
Read guide →
Buyer's Guide
Retatrutide Buyer's Guide 2026
How to find a reliable supplier for retatrutide research peptide — quality documentation to require, current price benchmarks ($12–$17/mg), red flags, and what makes sourcing this compound different from semaglutide or tirzepatide.
Read guide →
Buyer's Guide
How to Evaluate a Peptide Supplier
Reliability signals, red flags, due diligence questions, and the limits of what any evaluation can tell you — a neutral, evidence-based framework for supplier research.
Read guide →
Risk Analysis
What Can Go Wrong With Impure Peptides
Identity failures, dosing errors, endotoxin contamination, synthesis impurities — a category-by-category risk assessment based on available evidence, with honest acknowledgment of what remains uncertain.
Read guide →
Lab Directory
Peptide Testing Labs: Where to Send Your Sample
8 labs reviewed — Janoshik, Colmaric, Freedom Diagnostics, MZ Biolabs, Peptide Test, Chromate, Finnrick, and Testides. Prices, turnaround times, test types, and what the community actually says about each.
See lab directory →
Lab Review
Colmaric Analyticals: What They Test, Cost & Turnaround
HPLC, mass spec, and quantitative testing explained. Pricing, how to submit a sample, turnaround times, and a detailed Colmaric vs. Janoshik comparison.
Read review →
Explainer
How to Read a Peptide Certificate of Analysis
Field-by-field breakdown of what a CoA actually says — purity, identity, retention time, pass/fail designations, red flags, and the limits of what a certificate can and cannot tell you.
Read guide →
How-To Guide
How to Meaningfully Test a Peptide Sample
What a rigorous test actually involves — which tests to order (HPLC, MS, quantitative, endotoxin), how to prepare and ship a sample, what results mean, and the fundamental limits no test can overcome.
Read guide →
Explainer
HPLC vs Mass Spec vs Quantitative: What's the Difference?
Three tests, three different questions. Plain-language explanation of what each one measures, a side-by-side comparison table, common misconceptions corrected, and guidance on which to order for different situations.
Read guide →
Community Methods
Group Testing: How It Works and Whether It's Worth It
How cost-sharing group tests work, the Peptide Test platform explained, what group results can and cannot tell you, and an honest assessment of when group testing adds real value versus individual testing.
Read guide →
Storage Guide
Peptide Storage: Temperature, Degradation & Shelf Life
Lyophilized vs reconstituted storage requirements, bacteriostatic vs sterile water, what cloudy retatrutide means, whether you can freeze compounded tirzepatide, and how to recognize a degraded vial.
Read guide →
Practical Guide
Traveling with GLP-1 Medications
TSA rules for injectable medications and needles, temperature requirements by medication, what to pack, documentation to carry, and what to do when things go wrong — for domestic and international travel.
Read guide →
Guide
GHK-Cu Peptide: What the Evidence Actually Shows
Cancer safety concerns, topical vs. injectable differences, AHK-Cu comparison, purging reactions, and cycling considerations — an honest evidence review of the most-discussed copper peptide.
Read guide →
Safety Guide
Units vs. Milligrams: The Peptide Dosing Safety Guide
Converting between units and milligrams is one of the most common — and dangerous — errors in peptide dosing. A safety-critical guide to getting the math right every time.
Read guide →
Research Guide
Bryan Johnson's Peptide Protocol: What He Actually Uses (And What He Doesn't)
A factual breakdown of Bryan Johnson's documented peptide use — what's confirmed, what's been discontinued, what the evidence shows for each compound, and how his protocol compares to common biohacker stacks.
Read guide →
Research Guide
Performance Peptides vs. Longevity Peptides: Two Different Goals, Two Different Stacks
Performance peptides and longevity peptides pursue different biological endpoints — and the overlap is smaller than the marketing suggests. A framework for building a stack around your actual goal.
Read guide →
Research Guide
Epithalon and Telomere Research: What the Science Actually Shows
Epithalon's proposed mechanism involves telomerase activation and pineal gland support. What the animal and limited human research actually shows, and an honest assessment of where the evidence stands.
Read guide →
Research Guide
BPC-157 for Longevity and Healing: Separating the Evidence from the Hype
BPC-157 has a large base of animal research on healing and gut protection. What the evidence actually supports, what remains unproven, and how to think about it as a longevity compound vs. an acute recovery tool.
Read guide →
Analysis
The Peptide Influencer Landscape: What They Say vs. What the Evidence Shows
A systematic look at the most common claims made by peptide influencers — matched against the actual evidence. What's supported, what's overstated, and how to calibrate the signal-to-noise ratio in peptide content.
Read guide →
Safety Guide
TB-500 and the Wolverine Stack: What the Evidence Shows About Healing and Risk
TB-500 (Thymosin Beta-4), BPC-157, and the "Wolverine Stack" are among the most discussed healing peptide combinations. What the research actually shows, where the evidence is strong vs. thin, and what the risks are.
Read guide →
Research Guide
Loose Skin After Major Weight Loss: Peptides and Collagen
What the evidence shows for collagen peptides, GHK-Cu, BPC-157, and other peptides on skin elasticity and tissue remodeling after significant weight loss — with honest assessments of where the research is thin.
Read guide →
Safety Guide
Peptides and Psychiatric Medication Interactions
Known and theoretical interactions between research peptides and antidepressants, antipsychotics, mood stabilizers, and anxiolytics — what the evidence shows and what remains unknown.
Read guide →
Research Guide
GHK-Cu Complete Evidence Guide
A comprehensive review of GHK-Cu research — wound healing, collagen synthesis, anti-inflammatory activity, cancer safety concerns, topical vs. injectable comparisons, and an honest grading of the evidence base.
Read guide →
Research Guide
MOTS-C: Mitochondrial Peptide Evidence Guide
MOTS-c is a mitochondria-derived peptide with proposed roles in metabolic regulation, insulin sensitivity, and exercise response. What the preclinical and early human evidence shows, and where the research stands.
Read guide →
📚 Complete Guide Index

Every page in this resource, organized alphabetically.

→ Appeal & Prior Auth Letter Templates → Before Your Appointment Checklist → BPC-157 for Longevity and Healing: Separating the Evidence from the Hype → Bryan Johnson's Peptide Protocol: What He Actually Uses (And What He Doesn't) → GLP-1 Medications and Fertility: What to Know Before Trying to Conceive → Gallbladder Risk on GLP-1 Medications → Canada Generic Semaglutide: What US Patients Should Know → Compounded GLP-1: Quality & Safety Guide → Annual Cost Calculator → Cost of Not Treating Obesity → Cost Finder: Find My Best Option (Tool) → Duration Guide: How Long to Take GLP-1s → Employer Benefits Advocacy Toolkit → Epithalon and Telomere Research: What the Science Actually Shows → GLP-1 Medications and Illness: When Delayed Gastric Emptying Becomes a Risk → Injection Site Technique, Rotation, and Scarring: A Practical Guide → Insurance Coverage Guide → Medicaid Coverage by State → Medicare & GLP-1 Guide → Malnutrition Risk on GLP-1 Medications → Mochi Health and the State Pharmacy Investigation: What Patients Need to Know → Retaining Muscle on GLP-1 Medications: Protein, Creatine, and What the Evidence Shows → Negotiate a Lower Program Price → PAP Eligibility Screener (Free Medication) → Performance Peptides vs. Longevity Peptides: Two Different Goals, Two Different Stacks → Program Cost Breakdown Guide → Program Hidden Terms & Fine Print → Savings Cards, PAPs & Assistance Guide → HSA & FSA Eligibility Guide → Semaglutide vs. Tirzepatide Comparison → Side Effects Management Guide → Oral GLP-1 (Rybelsus): What's Different & What to Watch → Stopping & Discontinuation Guide → Why Bryan Johnson Stopped Tirzepatide: GLP-1s, Heart Rate, Sleep, and Longevity → Without Insurance: Self-Pay Options → Semaglutide Price Comparison (Live) → Semaglutide Programs Comparison → Tirzepatide Price Comparison (Live) → Tirzepatide Programs Comparison → Retatrutide Prices (Next-Gen GLP-1) → Semaglutide Research Peptide Guide → Tirzepatide Research Peptide Guide → Retatrutide: Triple Agonist Guide → Retatrutide Price Comparison & Supplier Guide → Peptide Testing: What CoAs Show (and What They Don't) → Retatrutide Buyer's Guide 2026 → Peptide Testing Labs Directory → How to Read a Certificate of Analysis → How to Meaningfully Test a Peptide Sample → HPLC vs Mass Spec vs Quantitative Testing → Group Testing: How It Works and Whether It's Worth It → Peptide Storage: Temperature, Degradation & Shelf Life → Traveling with GLP-1 Medications → Units vs. Milligrams: The Peptide Dosing Safety Guide → GLP-1 Medications vs. Bariatric Surgery: A Neutral Comparison → Weight Loss Plateau: Causes & Solutions → Switching Between GLP-1 Medications → Why GLP-1 Medications Are Inaccessible to Most Americans → GHK-Cu Peptide: What the Evidence Actually Shows → GLP-1 Benefits Beyond Weight Loss: Heart, Kidney, Brain & More → The Compounding Crackdown: What Happened & Where Things Stand → Your Compounded GLP-1 Program Is Ending: What to Do Now → Hims, Ro, and LifeMD GLP-1 Programs: What's Changing and What to Do → GLP-1 Emotional Blunting: What the Evidence Actually Shows → Your GLP-1 Options in 2026: Every Tier Explained → How to Vet a GLP-1 Telehealth Platform: Red Flags & Fraud Patterns → GLP-1 Medications and Thyroid Cancer: What the FDA Warning Actually Means → Compounding Pharmacies: How to Compare → Compounded Semaglutide: Base Form vs. Salt Form — What the Science Says → What Is Compounding & When Is It Legal? → Eden Health GLP-1 Review 2026 → Peptides & Fat Metabolism: Visceral Fat & BMR → Peptides & Metabolic Age: What the Science Shows → Peptide Influencer Landscape: What They Say vs. What the Evidence Shows → RFK Jr. and Peptide Reclassification: What the Policy Change Would Mean for Patients → TB-500 and the Wolverine Stack: What the Evidence Shows About Healing and Risk → Compounded GLP-1 Dosing and Concentration Safety → Generic GLP-1 Pricing and Prescription Wording → GHK-Cu Complete Evidence Guide → GLP-1 Long-Term Tolerance and Resistance → Loose Skin During GLP-1 Weight Loss → GLP-1 Medication Switching Guide → Emotional and Mental Health Effects of GLP-1 → GLP-1 Medications for Adolescents → Nutrition and Eating Guide While on GLP-1 → What Happens When You Stop GLP-1 Medications → GLP-1 Telehealth Provider Fraud and Consumer Protection → Weight Loss Plateaus on GLP-1 Medications → Loose Skin After Major Weight Loss: Peptides and Collagen → MOTS-C: Mitochondrial Peptide Evidence Guide → Peptides and Psychiatric Medication Interactions